ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling Pathway
Kaida Huang,1 Yubiao Lin,1 Keyin Wang,2 Jianfen Shen,3 Dahai Wei2– 4 1Department of Oncology, Xiamen Haicang Hospital, Xiamen, People’s Republic of China; 2Department of Infectious Diseases, Affiliated Hospital of Jiaxing University, Jiaxing, People’s Republic of China; 3Department of Central Labora...
Main Authors: | Huang K, Lin Y, Wang K, Shen J, Wei D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/arfip2-regulates-emt-and-autophagy-in-hepatocellular-carcinoma-in-part-peer-reviewed-fulltext-article-JHC |
Similar Items
-
FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis
by: Ran Wei, et al.
Published: (2019-03-01) -
Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway
by: Luo Li, et al.
Published: (2022-05-01) -
Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma
by: Linlin Qu, et al.
Published: (2023-05-01) -
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
by: Ming Chi, et al.
Published: (2022-05-01) -
Acetylshikonin inhibits the migration and invasion of A375 cells by reversing EMT process via the PI3K/Akt/mTOR pathway
by: Shuang Jiang, et al.
Published: (2019-01-01)